Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 21, 2023

SELL
$3.75 - $20.05 $506,531 - $2.71 Million
-135,075 Reduced 66.88%
66,878 $1.26 Million
Q1 2023

May 11, 2023

BUY
$3.67 - $4.92 $105,321 - $141,194
28,698 Added 16.56%
201,953 $775,000
Q4 2022

Feb 22, 2023

BUY
$4.55 - $6.31 $70,843 - $98,246
15,570 Added 9.87%
173,255 $859,000
Q3 2022

Nov 22, 2022

BUY
$4.48 - $6.47 $151,894 - $219,365
33,905 Added 27.39%
157,685 $754,000
Q3 2021

Nov 10, 2021

BUY
$5.02 - $6.59 $621,375 - $815,710
123,780 New
123,780 $702,000

Others Institutions Holding IMGN

About ImmunoGen, Inc.


  • Ticker IMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 220,712,992
  • Description
  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...
More about IMGN
Track This Portfolio

Track Teachers Retirement System Of The State Of Kentucky Portfolio

Follow Teachers Retirement System Of The State Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.